Syntax, a leading global technology solutions provider driving enterprise transformation in the cloud, today announced it has received a Golden Certificate from SAP® in recognition of 10 consecutive ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), ...

AI is changing what employers want from tech workers, but demand remains strong, according to an analysis of 2.85 million job ...

Syntax Bio expands Series A to $14.4M to boost CRISPR Cellgorithm platform and type 1 diabetes beta-cell therapy amid tough biotech funding—read more.

A five-character fix turned a failing Lighthouse Agentic Browsing audit into a clean pass. What that reveals about what the audit actually measures.

A local stem cell therapy company added several new investors as part of its Series A expansion. Learn more here.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), a leader in induced pluripotent stem cell (iPSC) technology and genome ...

After betting on AI, Ford reversed course and rehired hundreds of engineers. Here’s what every company got wrong about ...

At a TIME100 Talk in Cannes, industry insiders say AI is changing filmmaking, but humans remain the creative force behind the ...

The collaboration will evaluate Ajinomoto Group’s stem cell culture products using Syntax Bio’s programmable stem cell differentiation platform to support improved regenerative medicine discovery, ...